Model Number 11448964 |
Device Problem
Material Separation (1562)
|
Patient Problems
Chemical Exposure (2570); No Code Available (3191)
|
Event Date 05/27/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
No product will be returned per customer because the product was discarded.Admitting diagnosis: outpatient treatment for breast cancer although requested, information on race, ethnicity, and relevant history were not provided.
|
|
Event Description
|
It was reported from the durham regional cancer centre that when the nurse went to hang the cyclophosphamide chemotherapy bag on the intravenous (iv) pole, the secondary tubing set separated at the drip chamber.Although the nurse was wearing personal protective equipment (ppe), a small amount of chemotherapy medication splashed on the nurse's face and required medical assessment.Also, there was exposure of the cytotoxic chemotherapy medication on the patient's skin that did not require medical intervention.
|
|
Manufacturer Narrative
|
No product will be returned per customer.The customer complaint of tubing set separated at the drip chamber and leaked was confirmed.Photo provided by the customer shows that the tubing was completely separated from the drip chamber inlet port.Fluid was observed to be leaking from the separation.The root cause of this failure was not identified as no product was returned.Device history record for model 11448964 lot 20025679 shows that the set was manufactured on 13 february 2020 with a total of (b)(4) units.There were no qn¿s (quality notification) issued during the production build of this lot for the failure mode reported.
|
|
Event Description
|
It was reported from the durham regional cancer centre that when the nurse went to hang the cyclophosphamide chemotherapy bag on the intravenous (iv) pole, the secondary tubing set separated at the drip chamber.Although the nurse was wearing personal protective equipment (ppe), a small amount of chemotherapy medication splashed on the nurse's face and required medical assessment.Also, there was exposure of the cytotoxic chemotherapy medication on the patient's skin that did not require medical intervention.
|
|
Search Alerts/Recalls
|